NEW YORK (GenomeWeb News) – Rosetta Genomics said after the close of the market on Thursday it and Precision Therapeutics have amended their co-marketing deal entered into in July 2012 and revised in October.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.
Bloomberg profiles IndieBio, a startup incubator for the life sciences.
In an editorial, Nature calls for the end to the exploitation of foreign postdocs.
In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.
This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.
This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.